Huntington National Bank Sells 2,634 Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA)

Huntington National Bank cut its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 5.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 47,536 shares of the pharmacy operator’s stock after selling 2,634 shares during the period. Huntington National Bank’s holdings in Walgreens Boots Alliance were worth $2,015,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Savant Capital LLC grew its position in Walgreens Boots Alliance by 87.2% in the 1st quarter. Savant Capital LLC now owns 30,824 shares of the pharmacy operator’s stock worth $1,410,000 after purchasing an additional 14,359 shares in the last quarter. FDx Advisors Inc. grew its position in Walgreens Boots Alliance by 44.7% in the 1st quarter. FDx Advisors Inc. now owns 15,959 shares of the pharmacy operator’s stock worth $730,000 after purchasing an additional 4,928 shares in the last quarter. Assenagon Asset Management S.A. grew its position in Walgreens Boots Alliance by 27.3% in the 1st quarter. Assenagon Asset Management S.A. now owns 233,075 shares of the pharmacy operator’s stock worth $10,663,000 after purchasing an additional 49,936 shares in the last quarter. Pendal Group Ltd bought a new stake in Walgreens Boots Alliance in the 1st quarter worth about $134,000. Finally, Janney Montgomery Scott LLC grew its position in Walgreens Boots Alliance by 12.1% in the 1st quarter. Janney Montgomery Scott LLC now owns 314,807 shares of the pharmacy operator’s stock worth $14,402,000 after purchasing an additional 34,103 shares in the last quarter. 57.12% of the stock is owned by institutional investors.

A number of research analysts have recently weighed in on WBA shares. Mizuho reduced their target price on shares of Walgreens Boots Alliance from $48.00 to $43.00 and set a “neutral” rating for the company in a research report on Tuesday, July 21st. UBS Group raised shares of Walgreens Boots Alliance from a “sell” rating to a “neutral” rating and reduced their target price for the company from $49.00 to $44.00 in a research report on Monday, April 6th. Credit Suisse Group started coverage on shares of Walgreens Boots Alliance in a research report on Friday, July 10th. They set a “hold” rating and a $45.00 target price for the company. Zacks Investment Research downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “strong sell” rating and set a $42.00 target price for the company. in a research report on Friday, July 17th. Finally, Cowen reduced their target price on shares of Walgreens Boots Alliance from $54.00 to $48.00 and set a “market perform” rating for the company in a research report on Tuesday, May 19th. Four analysts have rated the stock with a sell rating and fourteen have given a hold rating to the stock. Walgreens Boots Alliance has a consensus rating of “Hold” and an average target price of $46.00.

NASDAQ WBA opened at $40.71 on Friday. Walgreens Boots Alliance Inc has a 1 year low of $36.65 and a 1 year high of $64.50. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.69 and a quick ratio of 0.33. The stock has a market capitalization of $35.28 billion, a PE ratio of 49.65, a P/E/G ratio of 1.74 and a beta of 0.55. The company’s 50 day simple moving average is $41.39 and its two-hundred day simple moving average is $45.26.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, July 9th. The pharmacy operator reported $0.83 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.10 by ($0.27). Walgreens Boots Alliance had a return on equity of 19.43% and a net margin of 0.55%. The firm had revenue of $34.63 billion during the quarter, compared to analysts’ expectations of $34.32 billion. During the same quarter in the prior year, the company earned $1.47 earnings per share. The business’s revenue for the quarter was up .1% compared to the same quarter last year. On average, research analysts anticipate that Walgreens Boots Alliance Inc will post 4.68 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Wednesday, August 19th will be paid a $0.4675 dividend. The ex-dividend date is Tuesday, August 18th. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.46. This represents a $1.87 annualized dividend and a yield of 4.59%. Walgreens Boots Alliance’s dividend payout ratio is currently 30.55%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Article: What does cost of debt say about a company’s financial health?

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.